Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Behrens M Kathleen, Director. Director active across 3 companies, notably Mimedx Group, INC.. Cumulatively, 36 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €1.9m. History available since 27 May 2021. The latest transaction was disclosed on 27 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Behrens M Kathleen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20,000 shares@ US$34.9248.8% of flowCommon StockSEC:0001209191-22-062287:0
25 of 36 declarations
About Behrens M Kathleen
BEHRENS M KATHLEEN is Administrateur at IGM Biosciences, Inc., Sarepta Therapeutics, Inc. and Mimedx Group, INC. She has 36 filings in total, and across the 36 sampled filings from 2021-05-28 to 2026-06-05, purchases total EUR 1851532 and sales total EUR 0. The most common transaction nature is Attribution.